Skip to search formSkip to main contentSkip to account menu

spiroglumide

Known as: 4-(3-chlorobenzamido)-5-(8-azaspiro(4.5)decan-8-yl)-5-oxopentanoic acid, 8-Azaspiro(4.5)decane-8-pentanoic acid, gamma-((3,5-dichlorobenzoyl)amino)-delta-oxo-, (R)- 
National Institutes of Health

Related topics

Related topics

3 relations

Narrower (1)

CR 2194

Broader (2)

Keto AcidsSpiro Compounds

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2012
Review
2012
New Molecular Targets for Treatment of Peptic Ulcer Disease
Most patients with peptic ulcer disease are currently treated with proton pump inhibitors or histamine H2 receptor antagonists… 
1996
1996
Effect of dexloxiglumide and spiroglumide, two new CCK‐receptor antagonists, on gastric emptying and secretion in the rat: evaluation of their receptor selectivity in vivo.
BACKGROUND: Clear definition of the role of CCK in the physiology of gastric motor activity has been long hampered by the lack of… 
1996
1996
Structure-antigastrin activity relationships of new spiroglumide amido acid derivatives.
A series of new spiroglumide amido acid derivatives was synthesized and evaluated for their ability to inhibit the binding of… 
1996
1996
Cytosolic Ca2+ evaluation in rabbit parietal cells: a novel method to screen gastrin receptor antagonists.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)